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Demonstration of the Mechanism 
of Transient Entrainment and 
Interruption of Ventricular 
Tachycardia With Rapid Atrial Pacing 
by A. L. Waldo, R. W.  Henthorn, V. J. Plumb, 
W. A. MacLean (17) 
ASS1Rtlfff 
An unusual case is presented in which ventricular tachycardia at 
a ,'ate of 141 beats/rain was transiently entrained by rapid 
atrialpacing at rates of 150, 155 and 160 beats/rain, and was 
interrupted by rapid atrial pacing at a rate of 165 beats/rain. 
During each period of transient entrainment, constant ventric- 
ular fusion beats were present except for the last entrained beat, 
and progressive ventricular fusion (di~erent fusion QRS com- 
plexes) was demonstrated when comparing QRS complex con- 
figurations during transient entrainment at each pacing rate. 
Interruption oft& ventricular tachycardia was associated with 
localized conduction block to the right ventricular ecording site, 
followed by activation of that site from a different direction and 
with a shorter conduction time by the subsequent pacing impulse. 
These data clearly distinguish transient entrainment of a 
tachycardia from overdrive suppression of a tachycardia, nd 
strongly suggest that reentry was the underlying mechanism of 
the ventricular tachycardia. 
Originally published in the Journal of the American College of Cardiology, 
February 1984. 
Review 
Beginning with Mayer's 1906 demonstration of  circus 
movement of  an electrical impulse in a ring of  tissue cut 
from the bell of  the Scyphomedusa (jellyfish) (1), scientists 
have pursued the mechanisms responsible for cardiac ar- 
rhythmias. Mines (2) and Garrey (3) demonstrated reentry 
in large tings of tissue cut from several types of hearts, and 
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since then almost a century of these studies has led to a 
descriptive classification ofarrhythmia mechanisms (4) (Ta- 
ble 1). Although many of these investigations have been 
motivated by pure academic uriosity, the compelling stim- 
ulus for most clinician scientists has been the pursuit of  the 
arrhythmologist's "golden fleece": the belief that under- 
50th Anniversary Historical Article 
INTRODUCTION 
In this edition of the Journal, we release the eleventh in a series 
of reviews of influential articles that have been previously 
pubfished in ACC journals, including the American Journal of 
Cardiology (from 1958 to 1982) and JACC (from 1983 to the 
presen0. The publication of these articles is only one aspect of the 
ACC's 50th anniversary commemoration, which highlights 50 
years of leadership in cardiovas~lar care and education. The 
articles are intended to encourage reflection on the remarkable 
progress made in cardiovascular medicine over time, as well as to 
acknowledge the amazing prescience ofsome early investigators in 
anticipating and, in many cases, later guiding developments in
their field. 
The working group responsible for selecting these articles and 
asking reviewers to write editorials solicited suggestions from 
the ACC's clinical committees and individual members. 
The group achieved consensus fairly easily, including whom the 
group should ask to prepare the accompanying editorials. We 
initially drew up a list of 14 general areas to cover in this series, 
but later found that there are several major areas of modem 
cardiology, prominently molecular cardiology, in which the truly 
landmark articles have, alas, not yet been published in JACC 
Therefore, the working roup decided not to categorize by subject, 
but instead, to concentrate on the most important articles. 
The working group, a task force of the Subcommittee for the 
Commemoration f the ACC 50th Anniversary, owes a great 
deal to Ms. May A. Roustom and the efficient and tireless taff 
at Heart House for facilitating this project. We also wish to 
thank all who suggested articles and, most important, the 
authors who prepared reviews for their willingness to contribute 
their time and wisdom. 
Influential ArtMes in JACC Working Group 
Sharon A. Hunt, M.D., F.A.C.C. 
Rick A. Nishimura, M.D., F.A.C.C. 
H.J.C. Swan, M.D., Ph.D., M.A.C.C. 
Michael J. Wolk, M.D., F.A.C.C. 
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Table 1. Mechanism of Arrhythmogenesis 
Disorders of impulse formation 
Enhanced normal automaticity 
Abnormal automaticity 
Triggered activity 
Early afterdepolarizations 
Delayed afterdepolarizations 
Disorders of impulse conduction 
Block 
Unidirectional block and reentry 
standing the electrophysiologic process(es) responsible for 
the initiation and maintenance of cardiac arrhythmias will 
lead to specific new ways of preventing arrhythmias and, less 
preferable but equally important, terminating them when 
they did occur. How have we done? 
Arrhytlunia termination. The termination part has been 
relatively easy. Beginning with the pioneering studies of 
Zoll (5), Lown (6), Schuder (7) and others over 30 years 
ago, direct current ransthoracic cardioversion has provided 
a safe and effective means for tachycardia termination. The 
implantation of a device, literally and figuratively, began 
with Mirowski's ventricular defibrillator 20 years ago (8), 
and within four years had expanded to incorporate the 
capability for synchronous ventricular cardioversion (9). An 
implantable device to automatically detect an arrhythmia 
and cardiovert/defibriUate th heart, radical at the time, has 
become the initial treatment of choice for patients with 
life-threatening ventricular tachyarrhythmias by consistently 
outperforming the best drugs available for these patients 
(]0). The implantable defibrillator concept most recently 
has broadened to encompass an atrial defibrillator (11). One 
of the reasons for the success of this form of therapy is that 
it is "generic" in the sense that the electric shock will be 
successful a most regardless of the arrhythmia mechanism or 
electrophysiologic milieu, a very different story from that of 
antiarrhythmic drugs (see later discussion). 
Arrhytlunia prevention. What about arrhythmia preven- 
tion? Drugs represent our mainstay for tachycardia preven- 
tion, but with their side effects or lack of efficacy, we have 
achieved, at best, a mediocre performance (12,13). Why? If 
we can understand the mechanism responsible for an 
arrhythmia, why can't we develop a drug that will interrupt 
that mechanism and prevent he arrhythmia, much as we 
target a specific antibiotic for a specific infectious organism? 
It simply isn't that straightforward, mostly because of the 
complexity of the ionic mechanisms that regulate cardiac 
electrophysiology. In addition, the unpredictable influence 
of exogenous factors such as ischemia, autonomic discharge 
or electrolyte changes compounds the interpatient and 
intrapatient variability. Furthermore, a channel-channel 
interaction can occur in such a way that changes in the 
function of one ion channel can have a domino effect on the 
function of succeeding ion channels. Confronted by the 
reality of such heterogeneity, one can begin to realize the 
almost impossible task faced by a drug that has only a single 
specific mechanism of action, such as the blocking of one 
ion channel. Differences in refractoriness or conduction 
velocity of several milliseconds can permit or prevent an 
arrhythmia from starting or perpetuating, and drugs that 
have only one function cannot be expected to exert high 
efficacy, owing to electrophysiologic variability. This may be 
why amiodarone, possessing electrophysiologic a tivity in all 
four drug classification categories, appears to be the leader in 
arrhythmia prevention (14). 
Radiofrequeney catheter ablation. Such mixed drug per- 
formance has birthed a plethora of many nonpharmacologic 
approaches for preventing arrhythmias, including the one 
exception to an otherwise ho-hum prevention result-- 
radiofrequency catheter ablation (15). This technique, 
founded on the understanding of arrhythmia mechanisms 
and locations, has revolutionized the treatment of patients 
with cardiac arrhythmias and has set the "ablationist" apart 
as the only cardiology specialist who actually cures a patient 
of his disease[ We now can eliminate, in a single procedure, 
atrial flutter, atrial tachycardias, atrioventricular (AV) node 
reentry, AV reentry and other Wolff-Parkinson-White 
(VdPW)-related arrhythmias with high success rates and 
minimal complications, and we are working on how to 
eliminate atrial fibrillation. In fact, focal causes of atrial 
fibrillation can be ablated with the same success rates as 
those for atrial tachycardias in general. It is a fascinating 
observation that these foci are often located in the pulmo- 
nary veins (16). In the ventricle, tachycardias in patients 
with normal hearts can be successfully ablated with accept- 
able reliability, whereas those associated with a cardiomy- 
opathy or coronary disease remain a challenge. 
Reentry and Waldo's observation. How did it come about 
that we were able to achieve such remarkable success with 
radiofrequency catheter ablation in so short a span? The 
timing was perfect in that the technique came after more 
than a decade of investigations that established mechanisms 
and sites responsible for clinical arrhythmias, and here is 
where Waldo's contribution (17), highlighted in this issue 
of the Journal of the American College of Cardiology, played a 
pivotal role. Since the early work on reentry (1-3), we have 
understood the electrophysiologic characteristics of slow 
conduction and unidirectional block that create this phe- 
nomenon, but demonstrating those features required in- 
heart recordings of the actual pathways traveled by the 
arrhythmia. This was a next-to-impossible feat at the time 
of Waldo's initial studies and is still very difficult today. 
Waldo showed us a new way that this might be done. 
Instead of having to record the actual pathways traveled by 
the arrhythmia, he demonstrated that if one could entrain 
the tachycardia--that is, increase the rate of the tachycardia 
to a faster rate by pacing, with resumption of the intrinsic 
rate of the tachycardia when pacing was stopped--the 
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Figure 1. Illustrated criteria for entrainment exemplified in a case 
of postinfarct ventricular tachycardia (VT). Left part of panel A, 
Two electrocardiographic (ECG) leads of a VT and intracardiac 
recordings from a mapping catheter (Map) at a left ventricular site 
critical for VT continuation, as well as from the right ventricular 
apex (RV). Note diastolic potential (thick arrow) during V"I'. 
Recordings are similarly arranged in all subsequent panels. Right 
part of panel A, Right ventricular pacing in the setting of sinus 
rhythm. Panel B, Right ventricular pacing at a cycle length (CL) 
slightly shorter than VT; this produces a Q RS complex that is a 
blend between flail V'I" and fuUy paced ("fusion"). All recordings 
are accelerated tothe paced CL, and after pacing ceases, the same 
VT resumes. Each fused Q_RS complex is identical and the last 
beat is entrained, but surface fusion is absent. Panels C and D, 
The same phenomena but at shorter paced CL; note that the fused 
Q_RS complex appears more similar to pacing than it does to VT 
as the pacing CL shortens. Panels B-D, Progressive degree of 
ECG fusion. The Map recording of panels B-D also shows a 
progression of fusion, with both the morphology and timing of a 
portion of the electrogram changing with faster pacing. Finally, a 
still shorter paced CL results in a sudden change in both the Map 
electrogram (block in the small diastolic potential, white arrow) 
and the surface ECG, which is now fully paced. When pacing 
ceases, VT has been interrupted. 
presence of reentry could be established (Fig. 1). By deduc- 
tive reasoning, he formulated a list of"rules" (Table 2) that 
a reentrant tachycardia would have to follow during such a 
pacing maneuver that would effectively set it apart from 
other mechanisms potentially responsible for the arrhyth- 
mia. He showed us that entrainment represented capture or 
continuous resetting of the reentrant circuit of the tachy- 
cardia by pacing-induced activation. Each pacing stimulus 
Table 2. Criteria to Establish the Presence of Transient 
Entrainment 
1. The demonstration f constant fusion beats in the 
electrocardiogram (ECG) during the period of rapid pacing 
at a constant rate, except for the last captured beat, which is 
entrained but not fused (i.e., the last entrained beat 
demonstrates the ECG morphology of the spontaneous 
tachycardia). 
2. The demonstration f progressive fusion (i.e., constant fusion 
beats in the ECG during rapid pacing at any constant rate, 
but different degrees of constant fusion at different rapid 
Fates). 
3. The demonstration that interruption of the tachycardia s 
associated with localized conduction block to a site(s) for one 
beat, followed by subsequent activation of that site(s) from a 
different direction, as manifested by a change in morphology 
of the electrogram atthe blocked site(s), and with a shorter 
conduction time. 
4. The demonstration f a change in conduction time and 
electrogram orphology at one recording site when pacing 
from another site at two different constant pacing rates, each 
of which is faster than the spontaneous rate of the 
tachycardia but fails to interrupt it (electrogram equivalent of 
progressive fusion). 
Reproduced with permission from Waldo  AL.  Atrial flutter: entrainment character- 
istics. J Cardiovasc Electrophysiol 1997;8:337-52. 
created a wave front that traveled in an anterograde direc- 
tion (orthodromic) and reset the tachycardia to the pacing 
rate. A wave front propagating in a retrograde direction 
(antidromic) collided with the orthodromic wave front of 
the previous beat (Fig. 2). These wave front interactions 
created electrocardiographic and electrophysiologic features 
that could be recorded easily and that could be explained 
only by reentry. This landmark advance nabled us, for the 
first time, to prove the reentrant nature of  the mechanism of" 
a clinical tachycardia by using catheter-based procedures, 
and it set the stage for applying these principles to help 
localize the pathways traveled by the tachycardia wave front 
(18). Such localization became essential in our use of 
ablation therapy to eradicate complex tachycardias. Thus, 
presently, an electrophysiologist  able to pace the heart 
during a tachycardia, establish whether reentry is present, 
determine whether the pacing site being used is near or 
within the reentrant circuit (or perhaps in a "blind loop" area 
not at all involved with the reentry) and deriver an ablating 
coup de grace. All of this followed from Waldo's seminal 
observation. 
The  next batdefront: sudden cardiac death. The arrhyth- 
mia story is certainly not finished. Sudden cardiac death 
remains a major health issue, accounting for 300,000 to 
400,000 deaths annually in the U.S. (19). Important gaps in 
our knowledge hinder the effective reduction of this mor- 
tality (20). Known risk factors are nonspecific, nonsensitive 
and nonmechanistic (i.e., they do not provide an under- 
standing of the mechanism causing the sudden cardiac 
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Figure 2. Diagram of the reentrant circuit during spontaneous atrial flutter and during transient entrainment ofthe atrial flutter. The left 
diagram shows the reentrant circuit during spontaneous type I atrial flutter (AFL). The "f" represents he circulating wave front of the 
atrial flutter. The middle diagram shows the introduction of the first pacing impulse (x) during rapid pacing from a high atrial site during 
the atrial flutter. The large arrow indicates the entry of the pacing impulse into the reentrant circuit, whereupon it is conducted 
,,rthodromically (Ortho) and antidromicaUy (Anti). the antidromic wave front of the pacing impulse (x) collides with the previous beat, 
m this case the circulating wave front of the spontaneous atrial flutter (f), resulting in an atrial fusion beat. This, in effect, terminates the 
atrial flutter. However, the orthodromic wave front from the pacing impulse (x) continues the tachycardia, resetting it to the pacing rate. 
The right diagram shows the introduction of the next pacing impulse (x + 1) during rapid pacing from the same high atrial site. The large 
arrow again indicates the entry of the pacing impulse into the reentrant circuit, whereupon it is conducted orthodromically and 
a~atidromically. Once again, the antidromic wave front from the pacing impulse (x + 1) collides with the orthodromic wave front of the 
p,cvious beat. In this case, it is the orthodromic wave front of the previous paced beat (x), resulting in an atrial fusion beat. The 
~,rthodromic wave front from the pacing impulse (x + 1) continues the tachycardia, resetting it to the pacing rate. The arrows indicate 
the direction of spread of the impulses; the serpentine line indicates low conduction through a presumed area of slow conduction 
(stippled region) in the reentrant circuit; and the black dots with tails indicate bipolar electrodes at the high atrial pacing site, the 
p,,steroinferior portion of the left atrium (PLA) and another atrial site. (Reproduced with permission from Waldo AL. Atrial flutter: 
etatrainment characteristics. J Cardiovasc Electrophysiol 1997;8:337-52.) 
A'ath). We frequently use anatomic end points, such as the 
i~rcsence of reduced ventricular function or the presence of 
c,,ronary artery disease as the risk factor, because we do not 
h.we useful electrophysiologic end points. Furthermore, 
when we do use an electrophysiologic end point, such as 
heart rate variability (21), baroreflex sensitivity (22) or the 
V esence of premature ventricular complexes (23), these risk 
factors fail to offer clues about the initiation and mainte- 
wance of the ventricular arrhythmia, thus precluding inter- 
vcntions based on their presence. T-wave dispersion (24), 
although important mechanistically, cannot be measured 
accurately from a scalar electrocardiogram t a paper speed 
of 25 mm/s, and it probably needs to be assessed with the 
atcuracy and completeness afforded by techniques such as 
body surface mapping. To search for late potentials, the 
s~gnal-averaged lectrocardiogram (25) should be helpful 
mechanistically, but it is too insensitive to be useful. The 
rdatively new test--T-wave alternans (26)--may be helpful 
in the future. Even when the spontaneous onset ofventric- 
ular tachycardia/fibrillation is recorded, distinguishing fea- 
tures of mechanistic causality are usually absent (27). More 
~mportantly, modification of some risk factors, when used as 
a surrogate for sudden cardiac death, can actually worsen the 
clinical outcome, as was found in the Cardiac Arrhythmia 
Suppression Trial (CAST) (28). These facts make it difficult 
to screen large groups and identify persons at risk before an 
arrhythmic event occurs, in a cost-effective manner and with 
a degree of sensitivity, specificity and predictive accuracy 
that justifies a major therapeutic intervention (such as 
implanting a cardioverter defibrillator prophylactically) (29). 
Substrate risk factor interaction. Although we understand 
the basis for many arrhythmic mechanisms, asnoted earlier, 
we do not understand very well the interactions between the 
anatomic/functional c rdiac substrate of a patient and the 
transient risk factors that finally precipitate sudden cardiac 
death in a particular individual (Fig. 3). For example, in 
WPW syndrome, the circuit for reentry is always present, 
yet tachycardia occurs in paroxysmal episodes. We under- 
stand the anatomy and electrophysiology of the WPW 
reentry circuit (i.e., we have studied the substrate), but the 
transient modulators that trigger the AV reentrant tachy- 
cardia are not well understood. Why did tachycardia start at 
10:00 AM this morning and not at 10:00 AM yesterday 
morning? The same can be stated regarding our understand- 
ing of patients with ventricular tachycardia pathways laid 
down by a myocardial infarction. Furthermore, our testing 
paradigms are limited because initiation of arrhythmias in 
most, but not all (30), animal models does not occur 
spontaneously (recent knockout mice models may prove 
useful). It is investigator-controlled, using methods uch as 
coronary occlusion/release, prolonged rapid pacing, drug 
administration a d autonomic manipulation. Some of these 
experimental manipulations do not accurately replicate the 
clinical onset of arrhythmias in patients with coronary 
disease and dilated cardiomyopathy, the two largest groups 
of patients with sudden cardiac death. These factors, plus 
the varied routes leading to the final common pathway of 
ventricular tachycardia/fibrillation r a bradyarrhythmia, 
make testing interventions difficult and hinder the arrhyth- 
mologist's quest o match a precise arrhythmia mechanism 
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Hgure 3. Venn diagram showing verlap between substrate characteristics, transient initiating events and intrinsic arrhythmia mechanisms 
to produce electromechanical dissociation (EMD) asystole, ventricular tachycardia (VT) or ventricular fibrillation (V-F). (Reproduced with 
permission from Zipes and Wellens [19].) 
with a specific therapeutic intervention. We may be close to 
achieving this goal in some disease states, such as the long 
Q T syndrome (31), but the latter is uncommon and 
represents he exception rather that the rule. Although we 
do have acceptable therapy to terminate the ventricular 
arrhythmia after its onset (i.e., the implantable cardioverter 
defibrillator), the biggest challenges are to identify the 
at-risk patient before the event occurs and then to prevent 
the ventricular arrhythmia from occurring at all. These two 
steps, identification and prevention, are very difficult to 
achieve given the present state-of-the-art, but in addition to 
prevention of the primary disease state, which is a very 
long-term goal, they are the most important long-term 
goals that we have. 
Investigative approach to sudden cardiac death. In the 
investigation of arrhythmic mechanisms, tudies on single 
ceUs and cellular elements are vital. These kinds of studies 
eliminate many of the ambiguities found in more complex 
in vitro preparations and intact organs, but the ambiguities 
themselves may be important factors in the development of 
some arrhythmias. Therefore, the powerful specificity af- 
forded by in vitro techniques must be integrated with less 
controUable but perhaps more clinically relevant in vivo 
studies. Indeed, some questions--for example, the role of 
transient risk factors--can be answered only by using in vivo 
animal models that faithfully replicate human conditions or, 
more probably, by studying patients themselves. Of the 
three major research pathways (basic, translational and 
clinical), the clinical utility of basic science inherently is 
associated with a high degree of clinical uncertainty. To 
reduce this level of uncertainty, some basic science needs to 
be focused on clinically relevant problems in order to 
provide a research structure that allows the rapid translation 
of the basic science advances to the clinic. Such an orien- 
tation requires close communication among individuals in 
all three disciplines, which can be achieved only by a 
propinquity that breeds interaction; all investigators must 
"share the same coffee pot" to promote discussion and the 
kind of relationship that results in clinical advances. Spe- 
cialized Centers of Research grants are ideal in this regard 
because they can be molded around a "clinical project that 
interweaves basic and translational research about a core of 
clinical issues. The animal projects can be designed to 
interact with, expand and supplement the objectives and 
hypotheses put forth in the clinical research. Thus, the 
research concepts emanate from the clinical problems and 
intersect with the animal studies at various levels, from 
molecular to in vitro to in vivo investigations. Clinician- 
scientists are needed to make this happen (32). 
The exploration of mechanisms responsible for sudden 
cardiac death must be divided into three parts. These 
include a search for the trigger precipitating the lethal 
cardiac arrhythmia,  study of the underlying substrate on 
which the trigger acts and an investigation of the interac- 
tion(s) between the two that caused the event hat generated 
the arrhythmia (Fig. 3). Substrates are much easier to 
control and characterize, and they therefore represent the 
bulk of most research efforts to date. Triggers are very 
difficult o evaluate because they are evanescent and variable, 
and there are few models apart from humans of truly 
JACC Vol. 35, No. 5, Suppl B 
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spontaneous sudden cardiac death. One of the generally 
accepted triggers is the autonomic nervous ystem through 
its influence on cardiac excitable properties (33). Because 
triggers must act on a receptive substrate to create an arrhyth- 
mia, one needs to also investigate myocardial structure- 
ttmction patterns, particularly when modulated by the 
autonomic nervous ystem. In addition, we now know that 
the heart can undergo progressive changes in structure and 
function owing to a variety of stimuli, such as rate (34-37), 
ischemia (38), stretch (39), genetic predisposition (40) and 
,,thers. Remodeling, as this process is often called, probably 
plays a crucial role in the pathogenesis of many arrhythmias, 
p.trticularly by influencing and potentially altering the elec- 
trophysiologic and anatomic milieu and interactions with 
triggers. Remodeling has different causes, depending on the 
l~fitiating event and its duration. Remodeling can range 
fi-om short-term alterations of ion concentration a d chan- 
~acl function, perhaps proceeding from metabolic influences, 
r,~ longer-term changes resulting from altered gene expres- 
~,,m in regulating protein synthesis and assembly, to very 
l,,ag-term structural revisions from damage caused by fibro- 
sis, fatty infiltration and similar processes (41). A better 
tHlderstanding of these changes will provide more insight 
into the arrhythmia mechanisms that precipitate sudden 
c.wdiac death and will aid in designing unique antiarrhyth- 
m~c approaches to prevent his calamity. 
Sudden cardiac death: what to do now? It is clear that the 
~,c.trch for solutions to the problem of sudden cardiac death 
~, challenging. Given the sustained effort that will be 
required to develop methods to accurately identify persons 
at risk, as well as ways to prevent sudden cardiac death, a 
,l~ort-term plan is necessary, founded on delivering cardio- 
?tdmonary resuscitation and defibrillation to the victim as 
s,,on as possible (42). In 1992, it was suggested that 
cardiopulmonary resuscitation training be given as a man- 
d,ltory course in high school to increase the pool of 
bystanders who might be able to help when a person has a 
cardiac arrest (43). It was also suggested that external 
defibrillators "be as accessible as fire extinguishers" (43). We 
must use such an approach now to be able to rapidly 
~csuscitate the victim of sudden cardiac death, while we also 
c,~ntinue to pursue our golden fleece. 
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